Impaired barrier function allows pathogenic microorganisms to stimulate nasal mucosal epithelial cells to produce inflammatory mediators, activating and recruiting various immune and inflammatory cells, including eosinophils, thus triggering an inflammatory cascade, and exacerbating histopathological changes in CRSwNP.35, 36 The expressions of systemic inflammation biomarkers, such as CRP, fibrinogen, IL-6, and TNF-α, were found to be enhanced in the serum of MetS patients.37 This evidence concerns the gene IL6 and metabolic syndrome.